Latest Commercial Partnerships News

Optiscan Imaging has lodged a 510(k) submission for its InForm digital pathology device, moving the product from development into formal US regulatory assessment. FDA clearance is not assured, but a successful determination could open the door to commercial distribution in the company’s target market.

H3 Energy has consolidated ownership of its Alinya hydrogen and helium project and reframed Warro as a potential commercial gas development, but its annual report warns that funding remains critical. The company ended FY2026 with A$900,434 in cash, net liabilities of A$551,671 and a material uncertainty over its ability to continue as a going concern.

Tungsten Mining has appointed Jefferies Australia to pursue strategic investors for its Watershed tungsten project, adding a global investment bank to a funding campaign already covering debt, offtake and government support. The move expands the options around a project with a reported A$1.309 billion pre-tax NPV8, but no funding deal or Final Investment Decision has been secured.

AdAlta says a 10-year, up to US$120 million agreement between manufacturing partner Oribiotech and an undisclosed commercial-stage biopharmaceutical company validates its choice of IRO automation for future cellular immunotherapies. The deal does not create direct revenue for AdAlta, and its lead asset EW-001 will continue with a separate manufacturing process.

Volt Resources has secured US$5.4 million in fully government-funded support for its US graphite refinery and customer application centre. The award is positive for project funding, but the company’s ASX securities remain suspended as it works with the exchange to satisfy reinstatement requirements.

Lithium Universe has secured selection for a proposed four-year Industry PhD project with Macquarie University and CSIRO to develop microwave-assisted recycling of end-of-life solar panels. The collaboration could strengthen the company’s technology pathway, but its grant, agreement and commercial outcomes remain unconfirmed.

Range International has replaced CEO Russell Kennett with Executive Chairman Richard Jenkins on an interim basis, with Jenkins to spend more time overseeing the company’s Indonesian operations. The restructure is expected to cut costs by up to 50%, although the company has not disclosed a baseline or implementation timetable.

Lithium Plus Minerals has significantly upgraded its Lei Lithium Project resource and secured a 20-year mining lease, positioning the company for near-term development and commercialisation.

Memphasys has secured product registration for its Felix™ System in Turkey, marking the start of commercial sales with an initial order of 100 cartridges and two consoles. The move taps into a large assisted-reproduction market with strong growth potential.

Recce Pharmaceuticals narrowed its operating loss to AUD 15 million in FY26, progressing Phase 3 trials for its anti-infective RECCE 327 and securing key patents and commercial partnerships.

4DS Memory Limited is set to acquire Australian Edge-AI software firm Jenesys, raising $5 million to integrate its autonomous systems capabilities with 4DS’s PCMO ReRAM technology, targeting computing-in-memory and neuromorphic markets.

Blue Star Helium has secured an extension of its helium offtake agreement at the Pinon Canyon Plant through March 2027, ensuring steady revenue while negotiating longer-term contracts.